Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study

Area of Science:

• Reproductive medicine
• Cardiovascular physiology
• Maternal-fetal medicine

Background:

• Gestational hypertension and preeclampsia are significant contributors to maternal and infant morbidity.
• Endothelin and eicosanoids like prostacyclin and thromboxane A2 play crucial roles in vascular homeostasis.
• Imbalances in these vasoactive substances are implicated in the pathophysiology of hypertensive disorders of pregnancy.

Purpose of the Study:

• To investigate the involvement of endothelin, prostacyclin, and thromboxane A2 in gestational hypertension and preeclampsia.
• To assess longitudinal changes in these mediators throughout pregnancy.

Main Methods:

• A longitudinal study involving 396 pregnant women.
• Collection of blood and 24-hour urine samples across trimesters.
• Assessed plasma endothelin and urinary metabolites of thromboxane A2 (thromboxane B2) and prostacyclin (6-keto-prostaglandin F1 alpha) in subgroups post-delivery.

Main Results:

• Endothelin levels decreased in the second trimester for all groups.
• Urinary excretion of thromboxane B2 and 6-keto-prostaglandin F1 alpha increased throughout pregnancy, with a decreasing ratio.
• No significant differences in endothelin, thromboxane B2, or 6-keto-prostaglandin F1 alpha levels were observed between women with preeclampsia, gestational hypertension, and normotensive controls.
• Only in severe preeclampsia and gestational hypertension were elevated second-trimester endothelin and increased thromboxane B2/6-keto-prostaglandin F1 alpha ratios noted.

Conclusions:

• This study found no evidence of prostacyclin deficiency or elevated endothelin in typical preeclampsia or gestational hypertension.
• Increased endothelin and a shift towards thromboxane dominance over prostacyclin were observed only in severe forms of these conditions.